- Home
- OGI vs MIST Comparison
OGI vs MIST Comparison
Compare OGI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | MIST |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 176.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OGI | MIST |
|---|---|---|
| Price | $1.56 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 813.8K | ★ 2.8M |
| Earning Date | 02-10-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $186,075,713.00 | N/A |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $6.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $0.63 |
| 52 Week High | $2.24 | $3.06 |
Technical Indicators
Market Signals| Indicator | OGI | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 39.25 | 35.98 |
| Support Level | $1.46 | $1.70 |
| Resistance Level | $1.64 | $2.02 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 18.15 | 15.89 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).